WeTrials
Recruiting

EQUAL: EGFR ctDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx Populations

What is this study?

This research study is looking at a new blood test to screen for a specific type of lung cancer in healthy people who are at risk and cannot have regular lung cancer screenings. The goal is to see if a simple blood test can find tiny pieces of cancer DNA floating in the blood.

Who can participate?

This study is currently recruiting adults who self-identify as East Asian, Southeast Asian, or Hispanic/Latinx and who are not current tobacco users: people aged 50 to 80, or aged 40 to 49 with a risk factor (a family history of EGFR-positive lung cancer, a past cancer that was resolved more than 5 years ago, tuberculosis, asthma needing daily inhaled steroids, chronic bronchitis, or possible lung cancer symptoms for the past month). You cannot join if you have had a chest CT scan in the past 3 years, have had cancer in the past 5 years, or have smoked more than 400 cigarettes (about 20 packs) in your lifetime.

What will happen?

Participants in this study will receive a special blood test that checks for changes in the EGFR gene related to lung cancer. If the test is positive, a second lab test checks the result, and a confirmed result is followed by a CT scan of the lungs. If the scan finds something, you will be referred for further evaluation; if it is clear, the scan is repeated after 12 months.

Where and when?

This study takes place at sites in Massachusetts, in the United States, and is currently recruiting new participants.

Key Points
  • 1Testing a new blood-based screening method for lung cancer
  • 2Open to healthy adults from specific Asian and Latinx backgrounds
  • 3Involves taking a blood sample to look for cancer DNA

Related video

Boston 25 News: Dana-Farber researchers explain the EQUAL blood-test study (October 2026)

Related links

Outside pages about this study, checked by our team

Suggest a link
Conditions Studied
This study is investigating treatments for the following conditions
Lung CancerEGFR Gene Mutation

This summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.